CALT Earnings

CALT reported its earnings on 2024-05-23, showcasing a revenue of against an estimate of , resulting in a 0% surprise. The EPS was -0.88, surpassing the expected -0.14 by -528.57% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following CALT's earnings announcement on 2024-05-23, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, CALT's stock price tends to shift by an average of +0.00% in the 10 days leading up to earnings and +0.00% in the 10 days following, providing insight into potential market.

For , analysts estimate CALT’s annual revenue to reach undefined, while the EPS is projected at undefined. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by % and EPS estimates No Change by % over the past three months, indicating analyst expectation in the company’s performance.

The correlation between CALT's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for were No Change by %, while EPS estimates moved No Change by % . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CALT's stock price typically moves by +0.00% in the 10 days before its earnings and +0.00% in the 10 days after. For the upcoming earnings, analysts expect an EPS of undefined and revenue of undefined.

The earnings call highlights strong year-over-year revenue growth for TARPEYO, despite a temporary revenue delay due to a cyberattack. The cash position remains healthy, and there are promising developments like FDA approval, expansion into China, and patent protection until 2043. The Q&A indicates positive expectations for KDIGO guidelines and EMA approval for Kinpeygo, which could expand the market. However, increased operating losses and management's lack of specific enrollment data are concerns. Given the market cap, the positive elements are likely to outweigh the negatives, suggesting a positive stock price movement.